Divestment
WuXi AppTec Divests China Clinical Services to Hillhouse Capital, Refocuses on Manufacturing Business
WuXi AppTec; Hillhouse Capital; divestment; clinical research services; CRDMO; manufacturing; China; WuXi Clinical; MedKey
BioMarin Plans to Divest Hemophilia Gene Therapy Roctavian Amid Strategic Refocus
BioMarin; Roctavian; hemophilia A; gene therapy; divestment; out-licensing; portfolio strategy; third quarter 2025; revenue challenge
Nektar Therapeutics Sells Alabama Manufacturing Facility and Reagent Business for $90 Million
Nektar Therapeutics, manufacturing site, reagent arm, divestment, Ampersand, $90 million
EU Approves Illumina’s Divestment Plan for Cancer Test Maker Grail
Illumina, Grail, EU clearance, Divestment, European Commission, Cancer diagnostic subsidiary, Capitalization terms
European Commission Grants Approval for Illumina to Divest Grail
Illumina, Grail, European Commission, Divestment, Competition, Antitrust